Lexagene Holdings (Lexagene Holdings) Gross Margin % : -341.86% (As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Lexagene Holdings's Gross Profit for the three months ended in Nov. 2022 was $-0.15 Mil. Lexagene Holdings's Revenue for the three months ended in Nov. 2022 was $0.04 Mil. Therefore, Lexagene Holdings's Gross Margin % for the quarter that ended in Nov. 2022 was -341.86%.

The historical rank and industry rank for Lexagene Holdings's Gross Margin % or its related term are showing as below:

LXXGQ's Gross Margin % is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 52.83
* Ranked among companies with meaningful Gross Margin % only.

Lexagene Holdings had a gross margin of -341.86% for the quarter that ended in Nov. 2022 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Lexagene Holdings was 0.00% per year.

Lexagene Holdings Gross Margin % Historical Data

The historical data trend for Lexagene Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Gross Margin % Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Gross Margin %

Get a 7-Day Free Trial

-174.14

-624.00

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Gross Margin %	Get a 7-Day Free Trial															-208.33	1,278.57	-940.00	-306.56	-341.86

Competitive Comparison of Lexagene Holdings's Gross Margin %

For the Medical Devices subindustry, Lexagene Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Gross Margin % falls into.

Lexagene Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Lexagene Holdings's Gross Margin for the fiscal year that ended in Feb. 2022 is calculated as

Gross Margin % (A: Feb. 2022 )	=	Gross Profit (A: Feb. 2022 )	/	Revenue (A: Feb. 2022 )
	=	-0.5	/	0.075
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.075 - 0.543)	/	0.075
	=	-624.00 %

Lexagene Holdings's Gross Margin for the quarter that ended in Nov. 2022 is calculated as

Gross Margin % (Q: Nov. 2022 )	=	Gross Profit (Q: Nov. 2022 )	/	Revenue (Q: Nov. 2022 )
	=	-0.1	/	0.043
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.043 - 0.19)	/	0.043
	=	-341.86 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Lexagene Holdings (OTCPK:LXXGQ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Lexagene Holdings had a gross margin of -341.86% for the quarter that ended in Nov. 2022 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Lexagene Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.